Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 2, 2006, Pages 687-693

  Jakobsson, Jenny ^a   Ekström, Lena ^a   Inotsume, Nobuo ^a,d   Garle, Mats ^a   Lorentzon, Mattias ^b   Ohlsson, Claes ^b   Roh, Hyung Keun ^c   Carlström, Kjell ^a   Rane, Anders ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c Inha University Hospital   (South Korea)

^d HOKKAIDO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCURONIDE; GLUCURONOSYLTRANSFERASE; TESTOSTERONE;

ADULT; ANDROGEN METABOLISM; ARTICLE; ETHNIC DIFFERENCE; GENE DELETION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HORMONE URINE LEVEL; HUMAN; KOREA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SWEDEN; TESTOSTERONE BLOOD LEVEL; URINALYSIS; URINARY EXCRETION;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; DNA; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOTYPE; GLUCURONOSYLTRANSFERASE; HUMANS; HYDROXYPROGESTERONES; KOREA; MALE; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SEX HORMONE-BINDING GLOBULIN; STATISTICS, NONPARAMETRIC; SWEDEN; TESTOSTERONE;

EID: 32544455635     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2005-1643     Document Type: Article

References (40)

1. van Houten ME, Gooren LJ 2000 Differences in reproductive endocrinology between Asian men and Caucasian men - a literature review. Asian J Androl 2:13-20
2. Hsing AW 2001 Hormones and prostate cancer: what's next? Epidemiol Rev 23:42-58
3. 1990 Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on Methods for the Regulation of Male Fertility. Lancet 336:955-959
4. 1996 Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil Steril 65:821-829
5. Shackleton CH, Phillips A, Chang T, Li Y 1997 Confirming testosterone administration by isotope ratio mass spectrometric analysis of urinary androstanediols. Steroids 62:379-387
6. Hsing AW, Reichardt JK, Stanczyk FZ 2002 Hormones and prostate cancer: current perspectives and future directions. Prostate 52:213-235
7. Hartgens F, KuipersH2004 Effects of androgenic-anabolic steroids in athletes. Sports Med 34:513-554
8. Dehennin L, Matsumoto AM 1993 Long-term administration of testosterone enanthate to normal men: alterations of the urinary profile of androgen metabolites potentially useful for detection of testosterone misuse in sport. J Steroid Biochem Mol Biol 44:179-189
9. Belanger A, Pelletier G, Labrie F, Barbier O, Chouinard S 2003 Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans. Trends Endocrinol Metab 14:473-479
10. Jin CJ, Miners JO, Lillywhite KJ, Mackenzie PI 1993 cDNA cloning and expression of two new members of the human liver UDP-glucuronosyltransferase 2B subfamily. Biochem Biophys Res Commun 194:496-503
11. Turgeon D, Chouinard S, Belanger P, Picard S, Labbe JF, Borgeat P, Belanger A 2003 Glucuronidation of arachidonic and linoleic acid metabolites by human UDP-glucuronosyltransferases. J Lipid Res 44:1182-1191
12. Turgeon D, Carrier JS, Levesque E, Hum DW, Belanger A 2001 Relative enzymatic activity, protein stability, and tissue distribution of human steroidmetabolizing UGT2B subfamily members. Endocrinology 142:778-787
13. Murata M, Warren EH, Riddell SR 2003 A human minor histocompatibility antigen resulting from differential expression due to a gene deletion. J Exp Med 197:1279-1289
14. Wilson 3rd W, Pardo-Manuel de Villena F, Lyn-Cook BD, Chatterjee PK, Bell TA, Detwiler DA, Gilmore RC, Valladeras IC, Wright CC, Threadgill DW, Grant DJ 2004 Characterization of a common deletion polymorphism of the UGT2B17 gene linked to UGT2B15. Genomics 84:707-714
15. Chung BC, Choo HY, Kim TW, Eom KD, Kwon OS, Suh J, Yang J, Park J 1990 Analysis of anabolic steroids using GC/MS with selected ion monitoring. J Anal Toxicol 14:91-95
16. Garle M, Ocka R, Palonek E, Bjorkhem I 1996 Increased urinary testosterone/epitestosterone ratios found in Swedish athletes in connection with a national control program. Evaluation of 28 cases. J Chromatogr B Biomed Appl 687: 55-59
17. Pardridge WM 1986 Serum bioavailability of sex steroid hormones. Clin Endocrinol Metab 15:259-278
18. Södergård R, Bäckström T, Shanbhag V, Carstensen H 1982 Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma proteins at body temperature. J Steroid Biochem 16:801-810
19. von Bahr C, Groth CG, Jansson H, Lundgren G, Lind M, Glaumann H 1980 Drug metabolism in human liver in vitro: establishment of a human liver bank. Clin Pharmacol Ther 27:711-725
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ 1951 Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
21. Narayanan R, LeDuc B, Williams DA 2000 Determination of the kinetics of rat UDP-glucuronosyltransferases (UGTs) in liver and intestine using HPLC. J Pharm Biomed Anal 22:527-540
22. Uralets VP, Gillette PA 1999 Over-the-counter anabolic steroids 4-androsten-3,17-dione; 4-androsten-3β,17β-diol; and 19-nor-4-androsten-3,17-dione: excretion studies in men. J Anal Toxicol 23:357-366
23. Ly LP, Handelsman DJ 2005 Empirical estimation of free testosterone from testosterone and sex hormone-binding globulin immunoassays. Eur J Endocrinol 152:471-478
24. Ross RK, Bernstein L, Lobo RA, Shimizu H, Stanczyk FZ, Pike MC, Henderson BE 1992 5-α-Reductase activity and risk of prostate cancer among Japanese and U.S. white and black males. Lancet 339:887-889
25. Lookingbill DP, Demers LM, Wang C, Leung A, Rittmaster RS, Santen RJ 1991 Clinical and biochemical parameters of androgen action in normal healthy Caucasian versus Chinese subjects. J Clin Endocrinol Metab 72:1242-1248
26. Santner SJ, Albertson B, Zhang GY, Zhang GH, Santulli M, Wang C, Demers LM, Shackleton C, Santen RJ 1998 Comparative rates of androgen production and metabolism in Caucasian and Chinese subjects. J Clin Endocrinol Metab 83:2104-2109
27. Jin B, Turner L, Zhou Z, Zhou EL, Handelsman DJ 1999 Ethnicity and migration as determinants of human prostate size. J Clin Endocrinol Metab 84:3613-3619
28. de Jong FH, Oishi K, Hayes RB, Bogdanowicz JF, Raatgever JW, van der Maas PJ, Yoshida O, Schroeder FH 1991 Peripheral hormone levels in controls and patients with prostatic cancer or benign prostatic hyperplasia: results from the Dutch-Japanese case-control study. Cancer Res 51:3445-3450
29. Heald AH, Ivison F, Anderson SG, Cruickshank K, Laing I, Gibson JM 2003 Significant ethnic variation in total and free testosterone concentration. Clin Endocrinol (Oxf) 58:262-266
30. Carlstrom K, Palonek E, Garle M, Oftebro H, Stanghelle J, Bjorkhem I 1992 Detection of testosterone administration by increased ratio between serum concentrations of testosterone and 17α-hydroxyprogesterone. Clin Chem 38: 1779-1784
31. Carlstrom K, Eriksson A, Stege R, Rannevik G 1990 Relationship between serum testosterone and sex hormone-binding globulin in adult men with intact or absent gonadal function. Int J Androl 13:67-73
32. Borts DJ, Bowers LD 2000 Direct measurement of urinary testosterone and epitestosterone conjugates using high-performance liquid chromatography/tandem mass spectrometry. J Mass Spectrom 35:50-61
33. Levesque E, Beaulieu M, Green MD, Tephly TR, Belanger A, Hum DW 1997 Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 7:317-325
34. Lampe JW, Bigler J, Bush AC, Potter JD 2000 Prevalence of polymorphisms in the human UDP-glucuronosyltransferase 2B family: UGT2B4(D458E), UGT2B7(H268Y), and UGT2B15(D85Y). Cancer Epidemiol Biomarkers Prev 9:329-333
35. Kuuranne T, Kurkela M, Thevis M, Schanzer W, Finel M, Kostiainen R 2003 Glucuronidation of anabolic androgenic steroids by recombinant human UDP-glucuronosyltransferases. Drug Metab Dispos 31:1117-1124
36. Huggins C, Hodges CV 2002 Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. J Urol 168:9-12
37. Oefelein MG 2003 Health related quality of life using serum testosterone as the trigger to re-dose long acting depot luteinizing hormone-releasing hormone agonists in patients with prostate cancer. J Urol 169:251-255
38. Haenszel W, KuriharaM1968 Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 40:43-68
39. Wolk A 2005 Diet, lifestyle and risk of prostate cancer. Acta Oncol 44:277-281
40. Barbier O, Lapointe H, El Alfy M, Hum DW, Belanger A 2000 Cellular localization of uridine diphosphoglucuronosyltransferase 2B enzymes in the human prostate by in situ hybridization and immunohistochemistry. J Clin Endocrinol Metab 85:4819-4826